x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:02:04

Just the Facts: Lightning Minerals pinpoints strong...

Proactive - Interviews for investors ·

2024/12/03

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Lightning Minerals Ltd (ASX:L1M). The company has identified strong lithium targets at its Caraíbas project in the Lithium Valley region of Minas Gerais, Brazil. Soil sampling assays have yielded values up to 239ppm lithium, with numerous results exceeding 100ppm, confirming a strong soil response within the Salinas Formation geological unit. The sampling program comprised 343 samples along 400-metre lines, identifying

en

00:02:01

Just the Facts: Percheron hits milestone in Duchenne...

Proactive - Interviews for investors ·

2024/12/02

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF). The company has reached a significant milestone in its Phase 2b clinical trial of avicursen (ATL-1102), a treatment for Duchenne muscular dystrophy. All 48 participants completed their week-25 visits, marking a key point in the trial focused on non-ambulant boys with advanced disease progression, a subgroup representing approximately half of the Duchenne population. Data

en

00:03:51

Energy Plug Technologies unveils Plug-and-Play...

Proactive - Interviews for investors ·

2024/12/02

Energy Plug Technologies CEO Broderick Gunning joined Steve Darling from Proactive to announce the launch of the company's latest innovation, the Off-Grid EV Charging Station, designed to bolster electric vehicle infrastructure in remote and underserved areas. This cutting-edge solution incorporates Energy Plug's advanced Battery Energy Storage System (BESS) and renewable energy technologies, offering a portable, eco-friendly alternative to traditional grid-dependent charging stations. The modular

en

00:05:59

Medicus Pharma’s Phase 2 study enrolls 25% of...

Proactive - Interviews for investors ·

2024/12/02

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to to announce a new agreement with Swanielle to explore expanding the Phase 2 clinical study of a potential treatment for Basal Cell Carcinoma (BCC) into the Asia-Pacific region. The ongoing Phase 2 study, currently being conducted at nine clinical sites in the United States, has already enrolled over 25% of the targeted 60 patients. Medicus Pharma plans to conduct an interim analysis of the data in Q1 2025 and submit the

en

00:03:59

U.S. Gold Corp. secures $10.2M in funding and...

Proactive - Interviews for investors ·

2024/12/02

U.S. Gold Corp. CEO Geroge Bee joined Steve Darling from Proactive to share significant updates about the company's latest developments. The company announced the successful execution of a securities purchase agreement in a registered direct offering, generating gross proceeds of approximately $10.2 million. The offering includes warrants exercisable six months after issuance and expiring three years from the initial issue date. Closing is anticipated on or around December 2, 2024, subject to

en

00:03:50

Volta Metals identifies new Lithium targets at Falcon...

Proactive - Interviews for investors ·

2024/12/02

Volta Metals CEO Kerem Usenmez joined Steve Darling from Proactive to share promising results from a mobile metal ion (MMI) soil sampling program at the Falcon West Lithium Project in Northwest Ontario. The sampling, guided by high-resolution aeromagnetic and LIDAR surveys, identified five primary and five secondary targets with anomalous lithium response ratios, suggesting strong potential for lithium-bearing pegmatites. The program not only targeted lithium but also cesium, tantalum, and

en

00:04:53

Power Nickel provides exploration update on Lion Zone...

Proactive - Interviews for investors ·

2024/12/02

Power Nickel Inc CEO Terry Lynch joined Steve Darling from Proactive to share an exploration update on the Lion Zone discovery at the Nisk Project near Nemaska, Quebec. Assays to date reveal that the Lion Zone extends over a strike length of 550 meters, adjacent to an ultramafic rock unit outcropping at surface for 1.8 kilometers. The winter drill program is advancing westward from the established 550-meter strike length, with step-out drilling at 150-meter intervals. Holes 76, 78, 79, 80, and 81

en

00:04:38

First Phosphate signs technology license with Prayon:...

Proactive - Interviews for investors ·

2024/12/02

First Phosphate's CEO, John Passalacqua joined Steve Darling from Proactive to announce the company’s agreement with Prayon SA of Belgium to license its advanced technology for producing merchant-grade phosphoric acid from igneous apatite phosphate rock, alongside high-purity gypsum. The license enables First Phosphate to design, build, and operate a manufacturing facility in Canada with a production capacity of 600 metric tons of phosphoric acid per day. To support the project, First Phosphate has

en

00:07:44

Zero Candida celebrates TSX Venture listing and...

Proactive - Interviews for investors ·

2024/12/02

Zero Candida Co-Founder and CEO Eli Ben-Haroosh joined Steve Darling from Proactive to mark a significant milestone as the company opened the market in celebration of its listing on the TSX Venture Exchange under the ticker symbol ZCT. The listing highlights the company’s mission to revolutionize women’s health with its groundbreaking technology. Zero Candida’s patented innovation leverages controlled “Blue Light” technology to effectively destroy fungal infections at unprecedented speed and

en

00:03:44

Candel Therapeutics advances Phase 2b trial for...

Proactive - Interviews for investors ·

2024/12/02

Candel Therapeutics Chief Medical Officer Garrett Nichols spoke with Steve Darling from Proactive to provide updates on the company’s Phase 2b trial of their innovative treatment, designed for patients with localized early prostate cancer. The trial involves 188 men with low to intermediate-risk prostate cancer—individuals who often choose active surveillance to avoid the side effects of invasive treatments. However, the psychological burden of potential disease progression frequently pushes

en

00:06:28

Immunic CSO discusses breaking the IBD stigma to mark...

Proactive - Interviews for investors ·

2024/12/02

Immunic Inc chief scientific officer Hella Kohlhof talked with Proactive's Stephen Gunnion about the significance of Crohn's and Colitis Awareness Week. She outlined the challenges of inflammatory bowel disease (IBD), a chronic and serious condition affecting the digestive tract. "It's not just a regular stomach issue; it's a lifelong disease," she explained, emphasizing the debilitating symptoms such as abdominal pain, fatigue, and weight loss. Kohlhof discussed Immunic's innovative research

en

00:04:31

Firebird Metals on LMFP battery strategy

Proactive - Interviews for investors ·

2024/12/02

Firebird Metals Ltd (ASX:FRB, OTC:FRBMF) managing director Peter Allen talks with Proactive’s Tylah Tully about the company’s LMFP strategy and its achievements in 2024. Allen shared insights on the growing importance of lithium manganese iron phosphate (LMFP) batteries, explaining how this technology improves energy density and range while maintaining safety and cost benefits. He highlighted the company’s advancements, including establishing a subsidiary in China, completing feasibility studies

en

00:01:45

Just the Facts: Great Boulder Resources hits...

Proactive - Interviews for investors ·

2024/12/02

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Great Boulder Resources Ltd (ASX:GBR). The company has received high-grade gold intersections from resource definition drilling at the Saltbush prospect within its Side Well Gold Project in Western Australia, which holds a mineral resource estimate of 668,000 ounces at 2.8 g/t gold. Recent drilling at Saltbush returned notable results, including 8 metres at 7.59 g/t from 12 metres with 5 metres at 10.14 g/t within that

en

00:01:59

Just the Facts: Orthocell achieves FDA study...

Proactive - Interviews for investors ·

2024/12/02

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Orthocell Ltd (ASX:OCC, OTC:ORHHF). The company has completed a pivotal US FDA 510(k) regulatory study for its nerve repair device, Remplir™, demonstrating its safety and efficacy in peripheral nerve surgery. This marks a critical step towards gaining US market clearance. The study met all required endpoints using a rat sciatic nerve model, showing that Remplir effectively regenerates nerves with outcomes comparable to an

en

00:04:40

Arrow Exploration Reports Record Q3 Results and...

Proactive - Interviews for investors ·

2024/11/29

Arrow Exploration CEO Marshall Abbott joined Steve Darling from Proactive to share a record-breaking Q3 performance and detailed plans for continued growth in 2025. The company achieved its strongest quarter ever in production, revenue, EBITDA, and cash flow. The company saw total revenue of $21.3 million, a 53% increase from Q3 2023. Net income of $6.7 million and adjusted EBITDA of $15.9 million, up 62% from Q3 2023 and 79% from Q2 2024. Operating cash flow of $29.2 million for the nine months

en

00:05:39

Bitcoin rally takes a breather while Ripple triples...

Proactive - Interviews for investors ·

2024/11/29

Proactive’s Billy Farrington joined Stephen Gunnion for the weekly Crypto Roundup, offering insights into the latest market developments. Bitcoin began the week with a sharp dip, dropping 5% on Monday. However, a midweek rebound saw Bitcoin stabilise at $97,200—just shy of its recent all-time high. Farrington explained, “The Trump trade sugar rush has tapered off,” highlighting that ETF inflows have slowed and retail investor interest appears to have cooled.Looking ahead, Farrington noted that

en

00:04:25

Faron Pharmaceuticals CMO discusses positive read-out...

Proactive - Interviews for investors ·

2024/11/29

Faron Pharmaceuticals Limited (AIM:FARN) chief medical officer Dr Petri Bono speaks with Proactive's Stephen Gunnion about the promising interim results from the phase II BEXMAB trial. This trial targets relapsed and refractory myelodysplastic syndrome (MDS) with their anti-Clever-1 antibody, bexmarilimab. Bono highlighted that BEXMAB treatment combined with azacitidine showed a median survival of 13.5 months, significantly surpassing the historical survival rate of 5 to 6 months. He noted an

en

00:02:18

Small cap wrap: European Lithium a strong mover of...

Proactive - Interviews for investors ·

2024/11/29

Proactive’s Tylah Tully gives another ‘Small Caps Wrap,’ outlining the biggest movers across the ASX small caps sector.Orthocell Ltd was among the strongest performers, rising nearly 34% to a weekly high of $0.83 before entering a trading halt at $0.81. The company’s share price surged after it announced a distribution agreement with Device Technologies Asia to exclusively market and distribute its nerve repair product Remplir™ in Singapore. This marks the product’s first significant

en

00:01:55

Just the Facts: Tryptamine Therapeutics successfully...

Proactive - Interviews for investors ·

2024/11/29

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Tryptamine Therapeutics Limited (ASX: TYP). Tryp has concluded its Phase 1b study of TRP-8803, an IV-infused psilocin-based formulation, in obese participants. Conducted at CMAX Clinical Research in Adelaide, the trial safely administered the treatment to three participants over a 140-minute period, completing the study within a week. This rapid timeframe highlights the formulation’s scalability and potential. TRP-8803

en

00:02:02

Just the Facts: Titan Minerals reports high-grade...

Proactive - Interviews for investors ·

2024/11/29

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Titan Minerals Ltd (ASX:TTM, OTC:TTTNF). The company has announced significant high-grade gold discoveries from trenching activities at the Dynasty Gold Project in Ecuador. At the Cerro Verde east and south prospect, trenching returned 2.1 metres at 32 g/t gold and 7.4 g/t silver, and another trench returned 2 metres at 7.3g/t gold and 6.1g/t silver. The trenching program has validated the potential of multiple targets

en

4,685 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...